Vessel Plus

🎉Exciting news! #VesselPlus has received its first Impact Factor:0.7 🎯A big thank you to our EiC Prof. Aijun Sun, authors, reviewers, and readers for your support. Let's advance vascular science together! 🧠🫀 #ImpactFactor #CardiovascularResearch #OpenAccess #VascularMedicine

🆕 New in @Vessel_Plus Bioresorbable scaffolds in #PAD 👍Temporary support, drug delivery, full resorption—reducing stent complications. 💥Latest review on tech, trials & future directions 👇 oaepublish.com/articles/2574-… #Endovascular #BioresorbableScaffolds

@docHJ Congratulations Dr. Jneid Well deserved 👏👏👏

Honored to be inducted into the Philosophical Society of Texas, founded in 1837 to promote scholarship, scientific inquiry, and the thoughtful exchange of ideas in Texas. Grateful to join a distinguished tradition that values intellect, service, and leadership for the public good. #TexasPhilosophicalSociety #Scholarship #Leadership #PublicGood #LifelongLearning

How geometry drives innovation in aortic valve repair 🫀 New insights into aortic root geometry show how the sinuses of Valsalva reduce cusp stress and improve durability. With 4D MRI, finite element models & AI, AV repair is moving personalized surgery. 🔗oaepublish.com/articles/2574-…

🎙 @Vessel_Plus Interview Spotlight Prof. Carl J. Lavie shares expert insights on: ✔️ Physical activity & #cardiorespiratory fitness ✔️ Inflammation & lipoprotein(a) ✔️ Obesity paradox & #cardiometabolic risk ✔️ Lifestyle + pharmacological #prevention 🔗oaepublish.com/interviews/vp.…

Prof. Bian highlights ECM regulation, precision pharmacology, and AI-driven advances in pulmonary #VascularResearch. #PulmonaryHypertension #CardiovascularResearch @heid_md @SeguraCardio @EuropePHA @TamCardio @docroham @PulmonaryNews @PHAssociation @pnatarajanmd @ankeetbhatt

🏆 Insights on #VascularBiology innovation from Prof. Jinsong Bian, #ASVB President 💡 ECM signaling & #PAH mechanisms 🤖 #AI + multi‑omics shaping precision therapy & education #PrecisionMedicine #Pharmacology #MedicalInnovation 🔗 Full interview: oaepublish.com/interviews/vp.…

🎄✨Wishing everyone a Merry Christmas! 🎅🎊May new season bring warmth, peace, and renewed hope!!!

We are so proud of everyone who received the O.H Frazier, M.D. Innovation and Leadership Award this year!

Sex-specific cardiac ageing matters: men and women differ in sympathetic compensation as the heart ages with big implications for prevention and treatment. Read more in #EHJ. doi.org/10.1093/eurhea… #gender #cardiotwitter @ESC_Journals @escardio

🔬Top 2% Global Scientist’s Cardio Insights: Prof. Barry A. Franklin 💪1 MET ↓16% mortality (aerobic+resistance training) 📈CRF>5 METs = low HF risk (HFpEF/HFrEF) 🚫No drug beats exercise: 7k-8k steps/5+flights 🧠Mentorship+balance=career success #CardioFitness #HeartRehab

🔬The “young-to-aged” paradigm in cardiovascular rejuvenation 🧬Exploring aging reversal strategies for cardiovascular & systemic health 💭Feasible breakthrough or science fiction? #CardiovascularHealth #AgingResearch #Rejuvenation #medicalinnovation 👉 oaepublish.com/articles/2574-…

🧠 Intracranial aneurysm segmentation with nnU-net 🔹 Advanced loss functions & automated vessel extraction 🔹 Improving segmentation accuracy in aneurysm detection 🔹 Potential for clinical application in diagnosis #Neuroimaging #AneurysmDetection 👉 oaepublish.com/articles/2574-…

A new, outstanding review of non-invasive imaging for coronary artery disease —"Most acute coronary syndromes occur in arterial segments with non-obstructive disease, which can be appreciated on CT coronary angiography but not on functional tests only detecting ischemia." —"Notably, in a Danish cohort study, up to 14% (725 out of 5043) of patients with flow-limiting stenoses had a CACS (calcium score) of 0" thelancet.com/journals/lance… Aligns with my recent GT review of the big shift to non-obstructive coronary atheroma erictopol.substack.com/publish/posts/…

🎙️ Vessel Plus Interview: Prof. Jin-Song Bian, President of the Asian Society for Vascular Biology (ASVB). 🔹TXNDC5’s role in ECM homeostasis & PH 💡 Precision treatments & AI in pharmacology education 🌍 ASVB 2026 insights #PH #Cardiology #VascularResearch #ASVB2026

Utilization and #discontinuation of secondary prevention pharmacotherapy after myocardial infarction: encouraging data ☀️academic.oup.com/ehjcvp/article…

Advances in imaging and hardware technologies created the opportunity for clinical visualization of molecules and cells that underpin atherosclerosis pathobiology. Read the new state of the art review! doi.org/10.1093/eurhea… #imaging #CardtoCT #OCT #cardiotwitter, @ESC_Journals, @escardio

📣 Call for Papers! 💥 Special Issue: Atrial Fibrillation: Diagnosis and Therapeutic Advances 📝 Deadline: Dec 31, 2025 View more: oaepublish.com/specials/vp.10… #AtrialFibrillation #Cardiology #HeartHealth #AFibResearch #TherapeuticAdvances #Diagnosis #ClinicalResearch

📢 Call for Papers! ✨Topic: Non-Coding RNAs in Vascular Pathophysiology and Therapeutic Advances 🧐Focus on ncRNAs’ role in vascular diseases 👉 oaepublish.com/specials/vp.23… #NonCodingRNAs #VascularResearch #Cardiology #MedicalResearch

This insightful study explores endothelial cell heterogeneity and #ImmuneMetabolic interactions in scleroderma using single-cell RNA sequencing. #Scleroderma #SingleCellRNA #PrecisionMedicine @ZainKhalpey @sclerodermaUM @SclerodermaCAN @SclerodermaNews @Worldsclerofnd

🧫 Endothelial cell heterogeneity in scleroderma 🔍 Insights from single-cell RNA sequencing ⚡ Reveals immune-metabolic interactions 🧠 Potential for novel therapeutic targets #EndothelialCells #SingleCellRNA #Immunometabolism 👉Read more: oaepublish.com/articles/2574-…